85090-9

LOINC 2.82

Citalopram and norcitalopram and didesmethylcitalopram panel - Serum or Plasma

Citalopram+metabolites Pnl SerPl

Definition

  • This panel contains tests used to evaluate treatment efficacy and manage dosage of citalopram, a selective serotonin uptake inhibitor used as an antidepressant. Norcitalopram and didesmethylcitalopram are active metabolites of citalopram.

Component

  • Citalopram & norcitalopram & didesmethylcitalopram panel

Specimen / system

  • Ser/Plas

Class

  • PANEL.DRUG/TOX

Property

  • -

Scale

  • -

Related names

  • Celexa; Cipramil; Citalopram metabolite; Citalopram+metabolites Pnl; Desmeth; Desmethylcitalopram; Didesmet-citalopram; DRUG/TOXICOLOGY; Drugs; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR

Index terms

  • Celexa
  • Cipramil
  • Citalopram & norcitalopram & didesmethylcitalopram panel
  • Citalopram metabolite
  • Citalopram+metabolites Pnl
  • Desmeth
  • Desmethylcitalopram
  • Didesmet-citalopram
  • DRUG/TOXICOLOGY
  • Drugs
  • Pan
  • PANEL.DRUG & TOXICOLOGY
  • Panl
  • Pl
  • Plasma
  • Plsm
  • Pnl
  • Point in time
  • Random
  • SerP
  • SerPl
  • SerPlas
  • Serum
  • Serum or plasma
  • SR